J 2023

Missorting of plasma miRNAs in aging and Alzheimer's disease

CARNA, Maria; Jan S. NOVOTNY; Neda DRAGISIC; Hanus SLAVIK; Kateřina SHEARDOVÁ et. al.

Basic information

Original name

Missorting of plasma miRNAs in aging and Alzheimer's disease

Authors

CARNA, Maria; Jan S. NOVOTNY; Neda DRAGISIC; Hanus SLAVIK; Kateřina SHEARDOVÁ; Yonas E. GEDA; Martin VYHNALEK; Jan LACZO; Jakub HORT; Zixu MAO; Robert A. RISSMAN; Marian HAJDUCH; Eric B. DAMMER and Gorazd B. STOKIN

Edition

Journal of Neurochemistry, Hoboken, Wiley-Blackwell, 2023, 0022-3042

Other information

Language

English

Type of outcome

Article in a journal

Field of Study

30210 Clinical neurology

Country of publisher

United States of America

Confidentiality degree

is not subject to a state or trade secret

References:

Impact factor

Impact factor: 4.200

RIV identification code

RIV/00216224:14110/23:00130750

Organization unit

Faculty of Medicine

UT WoS

000959282900001

EID Scopus

2-s2.0-85151484652

Keywords in English

aging; Alzheimer's disease; endosomes; extracellular vesicles; miRNA; ncRNA; plasma; short sequence motifs

Tags

Tags

International impact, Reviewed
Changed: 10/5/2023 14:06, Mgr. Tereza Miškechová

Abstract

In the original language

The observation that aging is regulated by microRNAs (miRNA) and at the same time represents the greatest risk factor for Alzheimer's disease (AD), prompted us to examine the circulating miRNA network in AD beyond aging. We here show that plasma miRNAs in aging are downregulated and predicted to be preferentially targeted to the extracellular vesicle (EV) content. In AD, miRNAs are further downregulated, display altered proportions of motifs relevant to their loading into EVs and secretion propensity, and are forecast to be found exclusively in EVs. The circulating miRNA network in AD, therefore, reflects pathological exacerbation of the aging process whereby physiological suppression of AD pathology by miRNAs becomes insufficient.